| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/19/2006 | US20060235201 Enduring T cell response |
| 10/19/2006 | US20060235200 Mutagenesis of aspergillus fungi and identification of genes essential for growth |
| 10/19/2006 | US20060235199 Reagent for amplifying amyloid fibrosis of amyloid ss-protein |
| 10/19/2006 | US20060234967 Human protooncogene and protein encoded therein |
| 10/19/2006 | US20060234937 Modulation of angiogenesis |
| 10/19/2006 | US20060234930 Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 10/19/2006 | US20060234925 Embryo implantation inhibitor |
| 10/19/2006 | US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis |
| 10/19/2006 | US20060234913 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia |
| 10/19/2006 | US20060234392 Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment |
| 10/19/2006 | US20060234391 Optical sensor based on resonant porous silicon structures |
| 10/19/2006 | US20060234390 Process for determining target function and identifying drug leads |
| 10/19/2006 | US20060234387 measuring the temperature of the flame as the sample is added to combustion chamber containing hydrogen fuel, oxygen oxidant and nitrogen neutral gas; using a flame temperature analyzer; prevent fire or explosion in industrial processes; energy efficiency; reduce emissions of volatile organic compounds |
| 10/19/2006 | US20060234386 Method and system for measuring lactate levels in vivo |
| 10/19/2006 | US20060234385 Polyglutamine repeat sequences |
| 10/19/2006 | US20060234384 Use of phosphonazo III for the measurement of calcium, magnesium and sodium in analytical samples |
| 10/19/2006 | US20060234383 Tissue assessment |
| 10/19/2006 | US20060234382 System and Method for Predicting Mold Growth in an Environment |
| 10/19/2006 | US20060234381 System and method for determining optimal reaction parameters using continuously running process |
| 10/19/2006 | US20060234380 grounding and mixing at least one component abounding in water and one water-free or low water component; using a Karl Fischer oven technique |
| 10/19/2006 | US20060234373 Treatment for diabetes |
| 10/19/2006 | US20060234350 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 10/19/2006 | US20060234344 Protein kinases |
| 10/19/2006 | US20060234332 Exposing liver tissue with enhanced cytochrome p450 expression to stimulus and using imaging analysis to detect cytotoxic features/damages generated thereafter |
| 10/19/2006 | US20060234329 Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics |
| 10/19/2006 | US20060234327 Methods for identifying enzyme inhibitors and protein kinases |
| 10/19/2006 | US20060234326 Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels |
| 10/19/2006 | US20060234325 Hematological assay and kit |
| 10/19/2006 | US20060234322 Ehrlichia canis DIVA (differentiate infected from vaccinated animals) |
| 10/19/2006 | US20060234321 Syphilis diagnostic tests and kits |
| 10/19/2006 | US20060234320 Pyroglutamyl peptidase and its gene |
| 10/19/2006 | US20060234319 urinalysis; pretreatment to add an acidic or alkaline solution and to heat the sample, excitation light irradiation process to irradiate the sample with the excitation light and to continuously or intermittently change the wavelength of the excitation light,emission light measurement, data analysis |
| 10/19/2006 | US20060234318 agent for detecting a cancer, which comprises a monoclonal antibody that specifically binds to a Mina 53 peptide; produced by hybridoma FERM BP-10157 |
| 10/19/2006 | US20060234317 Method of screening |
| 10/19/2006 | US20060234316 Methods for distinguishing type-1 from type-2 diabetes |
| 10/19/2006 | US20060234315 Markers for sudden death in heart failure |
| 10/19/2006 | US20060234314 Selective binding and analysis of macromolecules |
| 10/19/2006 | US20060234313 Modulation of angiogenesis through targeting of arginyl transferase (ATE1) |
| 10/19/2006 | US20060234312 Cell surface serine protease density as evaluative tool in detection of transplantation, autoimmunity, cancer and viral infection; monitoring of disease progression and pathologic phenomena that correlate with surface density of Human Leukocyte Elastase (HLE) associated with plasma membranes |
| 10/19/2006 | US20060234311 Isolating cells expressing secreted proteins |
| 10/19/2006 | US20060234310 Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods |
| 10/19/2006 | US20060234309 Quality assays for antigen presenting cells |
| 10/19/2006 | US20060234308 Method for determining the substrate specificity of an enzymatic activity and a device therefor |
| 10/19/2006 | US20060234306 Assay method |
| 10/19/2006 | US20060234305 Gene encoding G-protein coupled receptor and gene product thereof |
| 10/19/2006 | US20060234304 Diagnosis of acute myocardial, ischemic diseases |
| 10/19/2006 | US20060234301 Detecting autoimmune and nervous system disfunction via ratio between glycans and immunoglobulin binding agent or antibodies; earlier stage dectection |
| 10/19/2006 | US20060234300 Diagnosing an increased risk of suffering from a cardiovascular complication as a consequence of administration of a selective cyclooxygenase inhibitor, e.g., celecoxib, rofecoxib, or etoricoxib, by measuring a body fluid level of a natriuretic peptide; increased level indicates increased risk |
| 10/19/2006 | US20060234298 Systems and methods for rapidly changing the solution environment around sensors |
| 10/19/2006 | US20060234297 Screening method |
| 10/19/2006 | US20060234296 Method for generating high affinity antibodies |
| 10/19/2006 | US20060234295 Sandwich immunoassay for identifying partial proanp peptides |
| 10/19/2006 | US20060234294 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 10/19/2006 | US20060234292 Methods of diagnosing and treating diabetes and insulin resistance |
| 10/19/2006 | US20060234291 Site selective acylation |
| 10/19/2006 | US20060234289 Sp110, a polypeptide component of the nuclear body |
| 10/19/2006 | US20060234287 Breast cancer progression signatures |
| 10/19/2006 | US20060234286 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 10/19/2006 | US20060234285 For treating or preventing inflammatory diseases, autoimmune diseases, graft versus host disease (GVHD), allergis, asthma, and/or hepatitis; drug screening |
| 10/19/2006 | US20060234284 Methods of using molecular constructs for detection of biochemical reactions |
| 10/19/2006 | US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity |
| 10/19/2006 | US20060234282 Novel galanin receptor |
| 10/19/2006 | US20060234281 Novel galanin receptor |
| 10/19/2006 | US20060234279 Screening using polarization anisotropy in FRET emissions |
| 10/19/2006 | US20060234273 Id-1 and Id-2 genes and products as markers of epithelial cancer |
| 10/19/2006 | US20060234271 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 10/19/2006 | US20060234265 Microarrays having multi-functional, compartmentalized analysis areas and methods of use |
| 10/19/2006 | US20060234259 analyzing levels of actin-binding protein, alpha-methylacyl-CoA racemase, cylcin-dependent kinase 7, integrins, notch protein ligands, kindney anion exchanger adaptor proteins, monoclonal antibodies, mucins, metastasis-associated protein, prostate specific antigen, and tumor antigens; drug screening |
| 10/19/2006 | US20060234257 NOVX nucleic acids and their encoded polypeptides; diagnostic and therapeutic applications in the detection of a variety of diseases with differential expression in normal vs. diseased tissues, e.g., detection of a variety of cancers. |
| 10/19/2006 | US20060234256 Double stranded RNA receptor (dsRNA-R) and methods relating thereto |
| 10/19/2006 | US20060234255 Novel proteins and nucleic acids encoding same |
| 10/19/2006 | US20060234248 Composite organic inorganic nanoclusters |
| 10/19/2006 | US20060234246 diagnosing cancer; drug screening; inhibiting growth of a tumor cell by modulating expression of a gene product |
| 10/19/2006 | US20060234245 Pathogenic gene for coronary artery disease |
| 10/19/2006 | US20060234242 Methods for identifying therapeutic targets involved in glucose and lipid metabolism |
| 10/19/2006 | US20060234240 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 10/19/2006 | US20060234237 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 10/19/2006 | US20060234233 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 10/19/2006 | US20060234232 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 10/19/2006 | US20060234230 Method of detecting gene polymorphism |
| 10/19/2006 | US20060234229 Novel method for monitoring biomolecular interactions |
| 10/19/2006 | US20060234224 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 10/19/2006 | US20060234220 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 10/19/2006 | US20060234218 P450 proteins |
| 10/19/2006 | US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses |
| 10/19/2006 | US20060234210 Filtration device and method for removing selected materials from biological fluids |
| 10/19/2006 | US20060234209 Microchip-based system for hiv diagnostics |
| 10/19/2006 | US20060234208 Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 10/19/2006 | US20060234205 In vitro test system for predicting patient tolerability of therapeutic agents |
| 10/19/2006 | US20060234113 Electrochemical cells, and gas sensor and fuel cell devices comprising same |
| 10/19/2006 | US20060233861 Modulation of atp production or content in the hypothalamus |
| 10/19/2006 | US20060233836 Complex comprising peptide substrate such as synaptosomal associated protein, syntaxin, isoforms, vesicle-associated membrane protein, and motif of soluble NSF (N-ethylmaleimide-sensitive fusion protein) attachment protein receptor, reporter domain comprising red fluorescent protein |
| 10/19/2006 | US20060233826 Nucleotide sequences coding chlamydial membrane protein for use in generating neutralizing antibody which prevents micoorganismal infection |
| 10/19/2006 | US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 10/19/2006 | US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 10/19/2006 | US20060233819 Inhibition of T cell activation by butyrophilin 4 or B7-L1 |
| 10/19/2006 | US20060233818 Organic compounds |
| 10/19/2006 | US20060233817 Peptide-based immunization therapy for treatment of atherosclerosis |
| 10/19/2006 | US20060233812 Focussed antibody technology |
| 10/19/2006 | US20060233808 Peptabody for cancer treatment |